Antony Cherukara, CEO, VST Tillers Tractors Ltd., talks about the growth of the Q3FY22 numbers, raw material inflation, product launch pipeline, price hikes, 'Mission 2025', price hike plans, ...
Emerging immuno-oncology player Tessa Therapeutics has raised $80 million in a financing round that will be used to usher its virus-specific T cell (VST) immunotherapies through clinical trials. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results